These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 19306385

  • 1. Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.
    Newcorn JH, Donnelly C.
    Mt Sinai J Med; 2009 Apr; 76(2):198-203. PubMed ID: 19306385
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.
    Perrin JM, Friedman RA, Knilans TK, Black Box Working Group, Section on Cardiology and Cardiac Surgery.
    Pediatrics; 2008 Aug; 122(2):451-3. PubMed ID: 18676566
    [No Abstract] [Full Text] [Related]

  • 3. Stimulants and sudden death: what is a physician to do?
    Wilens TE, Prince JB, Spencer TJ, Biederman J.
    Pediatrics; 2006 Sep; 118(3):1215-9. PubMed ID: 16951018
    [Abstract] [Full Text] [Related]

  • 4. [Medication for ADHD and the risk of cardiovascular mortality].
    Kalverdijk LJ, Buitelaar JK, van der Gaag RJ.
    Ned Tijdschr Geneeskd; 2006 Oct 14; 150(41):2283-4; author reply 2284. PubMed ID: 17078147
    [No Abstract] [Full Text] [Related]

  • 5. Medications for attention deficit hyperactivity disorder: cardiovascular concerns.
    Wooltorton E.
    CMAJ; 2006 Jul 04; 175(1):29. PubMed ID: 16772535
    [No Abstract] [Full Text] [Related]

  • 6. [Attitude to questionable cadiac risks in stimulant administration].
    Fegert JM, Hebebrand J, Kommission Entwicklungspsychopharmakologie der drei Fachgesellschaften.
    Z Kinder Jugendpsychiatr Psychother; 2006 Jul 04; 34(4):295-7. PubMed ID: 16927572
    [No Abstract] [Full Text] [Related]

  • 7. ADHD drugs and cardiovascular risk.
    Rappley MD, Moore JW, Dokken D.
    N Engl J Med; 2006 May 25; 354(21):2296-8; author reply 2296-8. PubMed ID: 16729375
    [No Abstract] [Full Text] [Related]

  • 8. Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death.
    Knight M.
    Pediatrics; 2007 Jan 25; 119(1):154-5. PubMed ID: 17200281
    [No Abstract] [Full Text] [Related]

  • 9. ECGs before stimulants in children.
    Med Lett Drugs Ther; 2008 Jul 28; 50(1291):60. PubMed ID: 18654112
    [No Abstract] [Full Text] [Related]

  • 10. Stimulants for kids with ADHD--how to proceed safely.
    Ken Mehta S, Jacobs I.
    J Fam Pract; 2014 Feb 28; 63(2):E1-5. PubMed ID: 24527478
    [Abstract] [Full Text] [Related]

  • 11. [Treatment with central nervous system stimulants. Practical guidelines].
    Hvolby A, Jørgensen JI.
    Ugeskr Laeger; 2004 Jan 12; 166(3):144-8. PubMed ID: 14870640
    [No Abstract] [Full Text] [Related]

  • 12. Are stimulants overprescribed?
    Perry R, Gilbert EM, Angkustsiri K.
    J Am Acad Child Adolesc Psychiatry; 2000 Mar 12; 39(3):269-70; author reply 270-1. PubMed ID: 10714041
    [No Abstract] [Full Text] [Related]

  • 13. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ, Mautone JA, Manz PH, Frye L, Blum NJ.
    Pediatrics; 2008 Jan 12; 121(1):e65-72. PubMed ID: 18166546
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG, Gerhard T, Shuster J, Johnson M, Zito JM, Saidi A.
    Pediatrics; 2007 Dec 12; 120(6):e1494-501. PubMed ID: 18055666
    [Abstract] [Full Text] [Related]

  • 16. Debate over warnings for ADHD stimulants.
    Child Health Alert; 2006 Apr 12; 24():1. PubMed ID: 16673500
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ADHD drugs and cardiovascular risk.
    Nissen SE.
    N Engl J Med; 2006 Apr 06; 354(14):1445-8. PubMed ID: 16549404
    [No Abstract] [Full Text] [Related]

  • 19. Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder.
    Denchev P, Kaltman JR, Schoenbaum M, Vitiello B.
    Circulation; 2010 Mar 23; 121(11):1329-37. PubMed ID: 20212277
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.